Monday, 20 January 2020

VIANZ merges with Medicines New Zealand

09 August 2013 | News | By BioSpectrum Bureau

Singapore: The Vaccines Industry Association of New Zealand (VIANZ) has merged with the industry body Medicines New Zealand and will now represent the vaccine operations of the big pharmas such as Pfizer, Sanofi, Novartis, Merck & Co, GSK and bioCSL in the country.

According to Medicines New Zealand chairperson Ms Heather Roy, sharing resources and expertise will help the two organizations form a “practical and effective” partnership and provide a single point contact for all the stakeholders.

 

Tuberculosis (TB), rotavirus and brain cancer figure among the new vaccines that New Zealand researchers are working on.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls